These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 21684039)

  • 1. Mechanisms underlying altered striatal synaptic plasticity in old A53T-α synuclein overexpressing mice.
    Tozzi A; Costa C; Siliquini S; Tantucci M; Picconi B; Kurz A; Gispert S; Auburger G; Calabresi P
    Neurobiol Aging; 2012 Aug; 33(8):1792-9. PubMed ID: 21684039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A53T-alpha-synuclein overexpression impairs dopamine signaling and striatal synaptic plasticity in old mice.
    Kurz A; Double KL; Lastres-Becker I; Tozzi A; Tantucci M; Bockhart V; Bonin M; García-Arencibia M; Nuber S; Schlaudraff F; Liss B; Fernández-Ruiz J; Gerlach M; Wüllner U; Lüddens H; Calabresi P; Auburger G; Gispert S
    PLoS One; 2010 Jul; 5(7):e11464. PubMed ID: 20628651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice.
    Peneder TM; Scholze P; Berger ML; Reither H; Heinze G; Bertl J; Bauer J; Richfield EK; Hornykiewicz O; Pifl C
    Neuroscience; 2011 Apr; 180():280-92. PubMed ID: 21333719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of motor performance, brain biochemistry and histology of two A30P α-synuclein transgenic mouse strains.
    Piltonen M; Savolainen M; Patrikainen S; Baekelandt V; Myöhänen TT; Männistö PT
    Neuroscience; 2013 Feb; 231():157-68. PubMed ID: 23219665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice.
    Unger EL; Eve DJ; Perez XA; Reichenbach DK; Xu Y; Lee MK; Andrews AM
    Neurobiol Dis; 2006 Feb; 21(2):431-43. PubMed ID: 16230020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic dysfunction in Parkinson's disease.
    Picconi B; Piccoli G; Calabresi P
    Adv Exp Med Biol; 2012; 970():553-72. PubMed ID: 22351072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired dopamine release and synaptic plasticity in the striatum of PINK1-deficient mice.
    Kitada T; Pisani A; Porter DR; Yamaguchi H; Tscherter A; Martella G; Bonsi P; Zhang C; Pothos EN; Shen J
    Proc Natl Acad Sci U S A; 2007 Jul; 104(27):11441-6. PubMed ID: 17563363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease.
    Wakamatsu M; Iwata S; Funakoshi T; Yoshimoto M
    J Neurosci Res; 2008 Feb; 86(3):640-6. PubMed ID: 17896793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired plasticity at specific subset of striatal synapses in the Ts65Dn mouse model of Down syndrome.
    Di Filippo M; Tozzi A; Ghiglieri V; Picconi B; Costa C; Cipriani S; Tantucci M; Belcastro V; Calabresi P
    Biol Psychiatry; 2010 Apr; 67(7):666-71. PubMed ID: 19818432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein.
    Watson JB; Hatami A; David H; Masliah E; Roberts K; Evans CE; Levine MS
    Neuroscience; 2009 Mar; 159(2):501-13. PubMed ID: 19361478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Striatal dopamine transmission is subtly modified in human A53Tα-synuclein overexpressing mice.
    Platt NJ; Gispert S; Auburger G; Cragg SJ
    PLoS One; 2012; 7(5):e36397. PubMed ID: 22570709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic dysfunction in Parkinson's disease.
    Bagetta V; Ghiglieri V; Sgobio C; Calabresi P; Picconi B
    Biochem Soc Trans; 2010 Apr; 38(2):493-7. PubMed ID: 20298209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective noradrenergic vulnerability in α-synuclein transgenic mice.
    Sotiriou E; Vassilatis DK; Vila M; Stefanis L
    Neurobiol Aging; 2010 Dec; 31(12):2103-14. PubMed ID: 19152986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of striatal transcriptome in mice overexpressing human wild-type alpha-synuclein supports synaptic dysfunction and suggests mechanisms of neuroprotection for striatal neurons.
    Cabeza-Arvelaiz Y; Fleming SM; Richter F; Masliah E; Chesselet MF; Schiestl RH
    Mol Neurodegener; 2011 Dec; 6():83. PubMed ID: 22165993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease.
    Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A
    Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-synuclein A30P point-mutation generates age-dependent nigrostriatal deficiency in mice.
    Plaas M; Karis A; Innos J; Rebane E; Baekelandt V; Vaarmann A; Luuk H; Vasar E; Koks S
    J Physiol Pharmacol; 2008 Jun; 59(2):205-16. PubMed ID: 18622040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sub-regional differences and mechanisms of the short-term plasticity of dopamine overflow in striatum in mice lacking alpha-synuclein.
    Chadchankar H; Yavich L
    Brain Res; 2011 Nov; 1423():67-76. PubMed ID: 22000591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia.
    Errico F; Bonito-Oliva A; Bagetta V; Vitucci D; Romano R; Zianni E; Napolitano F; Marinucci S; Di Luca M; Calabresi P; Fisone G; Carta M; Picconi B; Gardoni F; Usiello A
    Exp Neurol; 2011 Dec; 232(2):240-50. PubMed ID: 21946266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human CU/ZN superoxide dismutase (GLY(93)-->ALA) mutation.
    Geracitano R; Paolucci E; Prisco S; Guatteo E; Zona C; Longone P; Ammassari-Teule M; Bernardi G; Berretta N; Mercuri NB
    Neuroscience; 2003; 118(2):399-408. PubMed ID: 12699776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exacerbated synucleinopathy in mice expressing A53T SNCA on a Snca null background.
    Cabin DE; Gispert-Sanchez S; Murphy D; Auburger G; Myers RR; Nussbaum RL
    Neurobiol Aging; 2005 Jan; 26(1):25-35. PubMed ID: 15585343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.